SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Talia Hatkevich, Joseph Ramos, Idalys Santos-Sanchez, Yashomati M. Patel, A naringenin–tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells, Experimental Cell Research, 2014, 327, 2, 331

    CrossRef

  2. 2
    Da Li, Fang-Fang Bi, Na-Na Chen, Ji-Min Cao, Wu-Ping Sun, Yi-Ming Zhou, Chun-Yan Li, Qing Yang, A novel crosstalk between BRCA1 and poly (ADP-ribose) polymerase 1 in breast cancer, Cell Cycle, 2014, 13, 21, 3442

    CrossRef

  3. 3
    Eldon R. Jupe, Kathie M. Dalessandri, John J. Mulvihill, Rei Miike, Nicholas S. Knowlton, Thomas W. Pugh, Lue Ping Zhao, Daniele C. DeFreese, Sharmila Manjeshwar, Bobby A. Gramling, John K. Wiencke, Christopher C. Benz, A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population, BBA Clinical, 2014, 2, 94

    CrossRef

  4. 4
    Guojiang Jin, Yan Zhao, Shuang Sun, Hui Kang, Association between the tumor necrosis factor alpha gene −308G> A polymorphism and the risk of breast cancer: a meta-analysis, Tumor Biology, 2014,

    CrossRef

  5. 5
    Benjamin O. Anderson, Breast cancer in Sub-Saharan Africa: Where can we go from here?, Journal of Surgical Oncology, 2014, 110, 8
  6. 6
    Dominique Sighoko, James D. Fackenthal, Pierre Hainaut, Changing in the pattern of breast cancer burden among African American women: evidence based on 29 states and District of Columbia during 1998 to 2010, Annals of Epidemiology, 2014,

    CrossRef

  7. 7
    Ching-Ting Tsao, Forrest M. Kievit, Kui Wang, Ariane E. Erickson, Richard G. Ellenbogen, Miqin Zhang, Chitosan-Based Thermoreversible Hydrogel as anin VitroTumor Microenvironment for Testing Breast Cancer Therapies, Molecular Pharmaceutics, 2014, 11, 7, 2134

    CrossRef

  8. 8
    Nabila S. Rattani, Theresa Swift-Scanlan, Deconstructing Breast Cancer Heterogeneity: Clinical Implications for Women With Basal-Like Tumors, Oncology Nursing Forum, 2014, 41, 6, 639

    CrossRef

  9. 9
    Gurleen Kaur, Mohinder P. Mahajan, Manoj K. Pandey, Parvesh Singh, Srinivasa R. Ramisetti, Arun K. Sharma, Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents, European Journal of Medicinal Chemistry, 2014, 86, 211

    CrossRef

  10. 10
    Jie Zhu, Zhibao Zheng, Jia Wang, Jinhua Sun, Pan Wang, Xianying Cheng, Lun Fu, Liming Zhang, Zuojun Wang, Zhaoyun Li, Different miRNA expression profiles between human breast cancer tumors and serum, Frontiers in Genetics, 2014, 5,

    CrossRef

  11. 11
    Amruta Ronghe, Anwesha Chatterjee, Bhupendra Singh, Prasad Dandawate, Leigh Murphy, Nimee K. Bhat, Subhash Padhye, Hari K. Bhat, Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog, The Journal of Steroid Biochemistry and Molecular Biology, 2014, 144, 500

    CrossRef

  12. 12
    Scott M Langevin, Susan M Pinney, Yuet-Kin Leung, Shuk-Mei Ho, Does epigenetic drift contribute to age-related increases in breast cancer risk?, Epigenomics, 2014, 6, 4, 367

    CrossRef

  13. 13
    I. Kyvernitakis, U-S. Albert, M. Kalder, A-S. Winarno, O. Hars, P. Hadji, Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer, Climacteric, 2014, 1

    CrossRef

  14. 14
    Ioannis Kyvernitakis, Tilman D. Rachner, Anja Urbschat, Olaf Hars, Lorenz C. Hofbauer, Peyman Hadji, Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer, Journal of Cancer Research and Clinical Oncology, 2014, 140, 10, 1671

    CrossRef

  15. 15
    Hady El Hachem, David Atallah, Michael Grynberg, Fertility preservation in breast cancer patients, Future Oncology, 2014, 10, 10, 1767

    CrossRef

  16. 16
    M. Feng, L. J. Pierce, Getting to the Heart of the Matter, JNCI Journal of the National Cancer Institute, 2014, 106, 8, dju210

    CrossRef

  17. 17
    Ming Zheng, Yinghui Zhou, Xiangmin Yang, Juan Tang, Ding Wei, Yang Zhang, Jian-Li Jiang, Zhi-nan Chen, Ping Zhu, High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients, Breast Cancer Research and Treatment, 2014, 148, 2, 423

    CrossRef

  18. 18
    Damian Junk, Benjamin Bryson, Mark Jackson, HiJAK’d Signaling; the STAT3 Paradox in Senescence and Cancer Progression, Cancers, 2014, 6, 2, 741

    CrossRef

  19. 19
    Hope S. Rugo, Hormone Therapy in Premenopausal Women with Early-Stage Breast Cancer, New England Journal of Medicine, 2014, 371, 2, 175

    CrossRef

  20. 20
    Natascia Marino, Joshua W. Collins, Changyu Shen, Natasha J. Caplen, Anand S. Merchant, Yesim Gökmen-Polar, Chirayu P. Goswami, Takashi Hoshino, Yongzhen Qian, George W. Sledge, Patricia S. Steeg, Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell lines, Clinical & Experimental Metastasis, 2014, 31, 7, 771

    CrossRef

  21. 21
    Esak Lee, Seung Jae Lee, Jacob E. Koskimaki, Zheyi Han, Niranjan B. Pandey, Aleksander S. Popel, Inhibition of breast cancer growth and metastasis by a biomimetic peptide, Scientific Reports, 2014, 4, 7139

    CrossRef

  22. 22
    Tomas Rodrigo Merino Lara, Emmanuelle Fleury, Shahram Mashouf, Joelle Helou, Claire McCann, Mark Ruschin, Anthony Kim, Nadiya Makhani, Ananth Ravi, Jean-Philippe Pignol, Measurement of Mean Cardiac Dose for Various Breast Irradiation Techniques and Corresponding Risk of Major Cardiovascular Event, Frontiers in Oncology, 2014, 4,

    CrossRef

  23. 23
    Anna Halama, Metabolomics in cell culture—A strategy to study crucial metabolic pathways in cancer development and the response to treatment, Archives of Biochemistry and Biophysics, 2014, 564, 100

    CrossRef

  24. 24
    Minghui Cao, Weiwei Nie, Jing Li, Yujing Zhang, Xin Yan, Xiaoxiang Guan, Xi Chen, Ke Zen, Chen-yu Zhang, Xiaohong Jiang, Dongxia Hou, MicroRNA-495 induces breast cancer cell migration by targeting JAM-A, Protein & Cell, 2014, 5, 11, 862

    CrossRef

  25. 25
    Jianxin Lv, Kai Xia, Pengfei Xu, Erhu Sun, Jingjing Ma, Sheng Gao, Qian Zhou, Min Zhang, Fengliang Wang, Fei Chen, Ping Zhou, Ziyi Fu, Hui Xie, miRNA expression patterns in chemoresistant breast cancer tissues, Biomedicine & Pharmacotherapy, 2014,

    CrossRef

  26. 26
    Benjamin C. Calhoun, Chad A. Livasy, Mitigating Overdiagnosis and Overtreatment in Breast Cancer: What Is the Role of the Pathologist?, Archives of Pathology & Laboratory Medicine, 2014, 138, 11, 1428

    CrossRef

  27. 27
    Ana de Macêdo Andrade, Carlos Ferreira Júnior, Beatriz Dantas Guimarães, Ana Pessoa Barros, Gibran Sarmento de Almeida, Mathias Weller, Molecular breast cancer subtypes and therapies in a public hospital of Northeastern Brazil, BMC Women's Health, 2014, 14, 1, 110

    CrossRef

  28. 28
    Xiaosong Zhang, Pamela N Munster, New protein kinase inhibitors in breast cancer: afatinib and neratinib, Expert Opinion on Pharmacotherapy, 2014, 15, 9, 1277

    CrossRef

  29. 29
    Hongsheng Guo, Fenping Wu, Yan Wang, chong Yan, wenmei Su, Overexpressed ubiquitin ligase Cullin7 in breast cancer promotes cell proliferation and invasion via down-regulating p53, Biochemical and Biophysical Research Communications, 2014, 450, 4, 1370

    CrossRef

  30. 30
    Debu Tripathy, Personalizing Management of Patients at Elevated Breast Cancer Risk: Where do we Start?, The Breast Journal, 2014, 20, 6
  31. 31
    Jame Abraham, PI3K/AKT/mTOR pathway inhibitors: the ideal combination partners for breast cancer therapies?, Expert Review of Anticancer Therapy, 2014, 1

    CrossRef

  32. 32
    Austin R. Dosch, Tulay Koru-Sengul, Feng Miao, Stacey L. Tannenbaum, Margaret M. Byrne, Jean L. Wright, Racial and ethnic disparities in the diagnosis of breast cancer: changes in presenting stage in minority populations in Florida during 1981–2009, Breast Cancer Research and Treatment, 2014, 148, 2, 379

    CrossRef

  33. 33
    Chun Wang, Jesse Civan, Yinzhi Lai, Massimo Cristofanilli, Terry Hyslop, Juan P. Palazzo, Ronald E. Myers, Bingshan Li, Zhong Ye, Kejin Zhang, Jinliang Xing, Hushan Yang, Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables, Cancer Causes & Control, 2014,

    CrossRef

  34. 34
    Jean L. Wright, Cristiane Takita, Isildinha M. Reis, Wei Zhao, Eunkyung Lee, Jennifer J. Hu, Racial Variations in Radiation-Induced Skin Toxicity Severity: Data From a Prospective Cohort Receiving Postmastectomy Radiation, International Journal of Radiation Oncology*Biology*Physics, 2014, 90, 2, 335

    CrossRef

  35. 35
    Takashi Yuri, Airo Tsubura, Relation between parity and pregnancy-related hormones and breast cancer control, Breast Cancer Management, 2014, 1

    CrossRef

  36. 36
    Rodrigo B. Interiano, Jun Yang, Adrian L. Harris, Andrew M. Davidoff, Seven In Absentia Homolog 2 (SIAH2) downregulation is associated with tamoxifen resistance in MCF-7 breast cancer cells, Journal of Surgical Research, 2014, 190, 1, 203

    CrossRef

  37. 37
    Arya Amini, Jessica D. McDermott, Gregory Gan, Shilpa Bhatia, Whitney Sumner, Christine M. Fisher, Antonio Jimeno, Daniel W. Bowles, David Raben, Sana D. Karam, Stereotactic Body Radiotherapy as Primary Therapy for Head and Neck Cancer in the Elderly or Patients with Poor Performance, Frontiers in Oncology, 2014, 4,

    CrossRef

  38. 38
    Dror Meirow, Hila Raanani, Ettie Maman, Shani Paluch-Shimon, Moran Shapira, Yoram Cohen, Irena Kuchuk, Ariel Hourvitz, Jacob Levron, Michal Mozer-Mendel, Masha Brengauz, Hana Biderman, Daphna Manela, Rephael Catane, Jehoshua Dor, Raoul Orvieto, Bella Kaufman, Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies, Fertility and Sterility, 2014, 102, 2, 488

    CrossRef

  39. 39
    Carlotta A. Glackin, Targeting the Twist and Wnt signaling pathways in metastatic breast cancer, Maturitas, 2014, 79, 1, 48

    CrossRef

  40. 40
    W Wei, Z-J Chen, K-S Zhang, X-L Yang, Y-M Wu, X-H Chen, H-B Huang, H-L Liu, S-H Cai, J Du, H-S Wang, The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo, Cell Death and Disease, 2014, 5, 10, e1428

    CrossRef

  41. 41
    Yuan Fang, Xinlan Qu, Boran Cheng, Yuanyuan Chen, Zhenmeng Wang, Fangfang Chen, Bin Xiong, The efficacy and safety of bevacizumab combined with chemotherapy in treatment of HER2-negative metastatic breast cancer: a meta-analysis based on published phase III trials, Tumor Biology, 2014,

    CrossRef

  42. 42
    Eun Hye Lee, Jae Kwan Jun, Seung Eun Jung, You Me Kim, Nami Choi, The Efficacy of Mammography Boot Camp to Improve the Performance of Radiologists, Korean Journal of Radiology, 2014, 15, 5, 578

    CrossRef

  43. 43
    Matthew Alcusky, Liane Philpotts, Machaon Bonafede, Janice Clarke, Alexandria Skoufalos, The Patient Burden of Screening Mammography Recall, Journal of Women's Health, 2014, 23, S1, S-11

    CrossRef

  44. 44
    Wei Wang, Jiang-Jiang Qin, Sukesh Voruganti, Kalkunte S. Srivenugopal, Subhasree Nag, Shivaputra Patil, Horrick Sharma, Ming-Hai Wang, Hui Wang, John K Buolamwini, Ruiwen Zhang, The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models, Nature Communications, 2014, 5, 5086

    CrossRef

  45. 45
    Y. Matsuo, J.-H. Park, T. Miyamoto, S. Yamamoto, S. Hisada, H. Alachkar, Y. Nakamura, TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis, Science Translational Medicine, 2014, 6, 259, 259ra145

    CrossRef

  46. 46
    Xinghua Li, Weijiang Liang, Junling Liu, Chuyong Lin, Shu Wu, Libing Song, Zhongyu Yuan, Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling, Breast Cancer Research, 2014, 16, 5

    CrossRef

  47. 47
    Paul Dowling, Valentina Palmerini, Michael Henry, Paula Meleady, Vincent Lynch, Jo Ballot, Giuseppe Gullo, John Crown, Michael Moriarty, Martin Clynes, Transferrin-bound proteins as potential biomarkers for advanced breast cancer patients, BBA Clinical, 2014, 2, 24

    CrossRef

  48. 48
    Panagiotis Apostolou, Maria Toloudi, Eleni Kourtidou, Georgia Mimikakou, Ioanna Vlachou, Marina Chatziioannou, Ioannis Papasotiriou, Use of the comet assay technique for quick and reliable prediction of in vitro response to chemotherapeutics in breast and colon cancer, Journal of Biological Research-Thessaloniki, 2014, 21, 1, 14

    CrossRef

  49. 49
    David R. Braxton, Cynthia Cohen, Momin T. Siddiqui, Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens, Diagnostic Cytopathology, 2014, 42, 12